Cookies help us run our site more efficiently.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information or to customize your cookie preferences.

Why Seasonal Allergies Are So Miserable

News Feed
Friday, April 19, 2024

Flowers and trees are in bloom—and so are pollen allergies.The sneezes, runny noses and itchy eyes that typically come with seasonal allergies are both miserable and extremely common. About one in four U.S. adults reported having seasonal allergies in 2021, according to the U.S. Centers for Disease Control and Prevention. And symptoms are getting worse and lasting longer: climate change is lengthening the growing season and exposing plants to higher carbon dioxide levels, causing them to produce more pollen. The tiny particles are not produced to hurt humans, so why do many of us react so poorly to them? It’s all an unfortunate consequence of our immune system’s attempts to navigate the world we live in.“The immune system is very complex, and it has a pretty tough job,” says Mansi Kanuga, an allergist at Mayo Clinic Health System. “It needs to be able to recognize things that can be dangerous to us and know when to fight those things off, and it also needs to know when to settle down.”On supporting science journalismIf you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.A human immune system has two parts: One mounts a general reaction to any foreign substance. Meanwhile the other responds to specific substances that the body has encountered before. The immune system will remember and develop dedicated resources to fight off those previous threats if the body runs into them again in the future. Allergies are such a target-specific immune response, and any substance that causes this kind of reaction is dubbed an allergen. “We can become allergic to any protein, really,” says Maya Jerath, an allergist at the Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital.How an allergy develops in the first place is still a bit of a mystery—but researchers have some solid theories. Scientists know babies aren’t born with specific allergies, Kanuga says, and they can come and go throughout someone’s life. Evidence also suggests genetics plays a role: children of parents with allergies are more likely to have them, too.Allergy formation is also determined by how reactive the immune system happens to be during the first exposure to a substance. If the system is particularly reactive, it’s likely to deem the substance a threat to watch out for in the future. Different exposure routes can also affect the likelihood of developing allergies. For example, a person’s immune system is more accustomed to seeing new substances pass through the gut, so it is less likely to respond to such substances than it might be to compounds first encountered through the skin—which rarely lets in outside material.But why is the immune system so markedly sensitive to pollen? After all, plants have dedicated defense mechanisms against herbivory, such as thorns and bitter-tasting chemicals, which don’t trigger seasonal allergies. Pollen is merely a substance plants use to reproduce—the botanical equivalent of sperm—and didn’t evolve to fend off humans. “You are not the target; they’re not trying to make the allergy,” says Nabarun Ghosh, a biologist at West Texas A&M University, who specializes in studying allergens.Unfortunately, your immune system may not be willing to listen to reason about this. Pollen is difficult to acclimate to because it’s seasonal rather than consistently present in the environment. In addition, the tiny, airborne pollen grains that cause allergies can easily make their way past the nose and deeper into the respiratory tract. In general, however, allergies develop because the immune system is reactive when it first meets an allergen; the conditions don’t arise from any specific characteristic of the pollen itself.Environmental allergies are mediated by a protein called immunoglobulin E, or IgE. Such an allergy’s initial development triggers the production of IgE molecules that are able to bind to the specific allergen. When the immune system detects the allergen again, it churns out IgE proteins, which bind to the surface of the body’s protective mast cells as scouts. When a scout IgE binds to the allergen, the mast cell releases a cocktail of chemicals—including histamines and other inflammatory substances that trigger the congestion, watery eyes and sneezing that we associate with allergies. An allergic response tends to remain strongest in the body part where the allergen was mainly encountered—so inhaling pollen might make your nose run, whereas getting it in your eyes might make them water.While it might be tempting to hate on IgE and mast cells, this branch of the immune system has a long history of protecting people from parasitic infections. Modern humans don’t encounter these threats as often, so it’s easy to paint allergies as an overreaction.Allergies are “your body’s immune system thinking that it’s doing the right thing,” says Emily Weis, an allergist at the University of Rochester Medical Center. “The immune system is always trying to differentiate between self and not self. That’s what has kept us alive.”That’s cold comfort for allergy sufferers, of course. “We really recognize that seasonal allergies take a big toll on our quality of life for those of us who suffer with them,” Kanuga says. She, Weis and Jerath offer a three-pronged approach to living with allergies.First, reduce exposure to known allergens when possible. This can include monitoring local pollen levels to determine when to spend time outside and leaving your windows closed to keep your house pollen-free. When you do have symptoms, antihistamines and other over-the-counter medicines can help manage itching, sneezing and watery eyes.If these approaches aren’t sufficient, consider talking to an allergist about immunotherapy, which most commonly means allergy shots. These shots contain a personalized mixture of your allergens at low doses and act to desensitize your immune system, teaching it to tolerate these materials rather than unleash mast cells in their presence. In the U.S., immunotherapy is also available in tablet form for grass and ragweed pollens, as well as dust mites.It does take time to see results: treatment with allergy shots can take about six months to improve symptoms and five years to complete, Jerath says. Still, she says, this approach is an impressive way to actually diminish allergies instead of just treating their symptoms. “It’s a little bit mind-blowing,” she adds, “to think about the fact that you can actually retrain the immune system.”

Plants are just trying to reproduce; immune systems are just trying to keep us safe

Flowers and trees are in bloom—and so are pollen allergies.

The sneezes, runny noses and itchy eyes that typically come with seasonal allergies are both miserable and extremely common. About one in four U.S. adults reported having seasonal allergies in 2021, according to the U.S. Centers for Disease Control and Prevention. And symptoms are getting worse and lasting longer: climate change is lengthening the growing season and exposing plants to higher carbon dioxide levels, causing them to produce more pollen. The tiny particles are not produced to hurt humans, so why do many of us react so poorly to them? It’s all an unfortunate consequence of our immune system’s attempts to navigate the world we live in.

“The immune system is very complex, and it has a pretty tough job,” says Mansi Kanuga, an allergist at Mayo Clinic Health System. “It needs to be able to recognize things that can be dangerous to us and know when to fight those things off, and it also needs to know when to settle down.”


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


A human immune system has two parts: One mounts a general reaction to any foreign substance. Meanwhile the other responds to specific substances that the body has encountered before. The immune system will remember and develop dedicated resources to fight off those previous threats if the body runs into them again in the future. Allergies are such a target-specific immune response, and any substance that causes this kind of reaction is dubbed an allergen. “We can become allergic to any protein, really,” says Maya Jerath, an allergist at the Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital.

How an allergy develops in the first place is still a bit of a mystery—but researchers have some solid theories. Scientists know babies aren’t born with specific allergies, Kanuga says, and they can come and go throughout someone’s life. Evidence also suggests genetics plays a role: children of parents with allergies are more likely to have them, too.

Allergy formation is also determined by how reactive the immune system happens to be during the first exposure to a substance. If the system is particularly reactive, it’s likely to deem the substance a threat to watch out for in the future. Different exposure routes can also affect the likelihood of developing allergies. For example, a person’s immune system is more accustomed to seeing new substances pass through the gut, so it is less likely to respond to such substances than it might be to compounds first encountered through the skin—which rarely lets in outside material.

But why is the immune system so markedly sensitive to pollen? After all, plants have dedicated defense mechanisms against herbivory, such as thorns and bitter-tasting chemicals, which don’t trigger seasonal allergies. Pollen is merely a substance plants use to reproduce—the botanical equivalent of sperm—and didn’t evolve to fend off humans. “You are not the target; they’re not trying to make the allergy,” says Nabarun Ghosh, a biologist at West Texas A&M University, who specializes in studying allergens.

Unfortunately, your immune system may not be willing to listen to reason about this. Pollen is difficult to acclimate to because it’s seasonal rather than consistently present in the environment. In addition, the tiny, airborne pollen grains that cause allergies can easily make their way past the nose and deeper into the respiratory tract. In general, however, allergies develop because the immune system is reactive when it first meets an allergen; the conditions don’t arise from any specific characteristic of the pollen itself.

Environmental allergies are mediated by a protein called immunoglobulin E, or IgE. Such an allergy’s initial development triggers the production of IgE molecules that are able to bind to the specific allergen. When the immune system detects the allergen again, it churns out IgE proteins, which bind to the surface of the body’s protective mast cells as scouts. When a scout IgE binds to the allergen, the mast cell releases a cocktail of chemicals—including histamines and other inflammatory substances that trigger the congestion, watery eyes and sneezing that we associate with allergies. An allergic response tends to remain strongest in the body part where the allergen was mainly encountered—so inhaling pollen might make your nose run, whereas getting it in your eyes might make them water.

While it might be tempting to hate on IgE and mast cells, this branch of the immune system has a long history of protecting people from parasitic infections. Modern humans don’t encounter these threats as often, so it’s easy to paint allergies as an overreaction.

Allergies are “your body’s immune system thinking that it’s doing the right thing,” says Emily Weis, an allergist at the University of Rochester Medical Center. “The immune system is always trying to differentiate between self and not self. That’s what has kept us alive.”

That’s cold comfort for allergy sufferers, of course. “We really recognize that seasonal allergies take a big toll on our quality of life for those of us who suffer with them,” Kanuga says. She, Weis and Jerath offer a three-pronged approach to living with allergies.

First, reduce exposure to known allergens when possible. This can include monitoring local pollen levels to determine when to spend time outside and leaving your windows closed to keep your house pollen-free. When you do have symptoms, antihistamines and other over-the-counter medicines can help manage itching, sneezing and watery eyes.

If these approaches aren’t sufficient, consider talking to an allergist about immunotherapy, which most commonly means allergy shots. These shots contain a personalized mixture of your allergens at low doses and act to desensitize your immune system, teaching it to tolerate these materials rather than unleash mast cells in their presence. In the U.S., immunotherapy is also available in tablet form for grass and ragweed pollens, as well as dust mites.

It does take time to see results: treatment with allergy shots can take about six months to improve symptoms and five years to complete, Jerath says. Still, she says, this approach is an impressive way to actually diminish allergies instead of just treating their symptoms. “It’s a little bit mind-blowing,” she adds, “to think about the fact that you can actually retrain the immune system.”

Read the full story here.
Photos courtesy of

China Announces Another New Trade Measure Against Japan as Tensions Rise

China has escalated its trade tensions with Japan by launching an investigation into imported dichlorosilane, a chemical gas used in making semiconductors

BEIJING (AP) — China escalated its trade tensions with Japan on Wednesday by launching an investigation into imported dichlorosilane, a chemical gas used in making semiconductors, a day after it imposed curbs on the export of so-called dual-use goods that could be used by Japan’s military.The Chinese Commerce Ministry said in a statement that it had launched the investigation following an application from the domestic industry showing the price of dichlorosilane imported from Japan had decreased 31% between 2022 and 2024.“The dumping of imported products from Japan has damaged the production and operation of our domestic industry,” the ministry said.The measure comes a day after Beijing banned exports to Japan of dual-use goods that can have military applications.Beijing has been showing mounting displeasure with Tokyo after new Japanese Prime Minister Sanae Takaichi suggested late last year that her nation's military could intervene if China were to take action against Taiwan — an island democracy that Beijing considers its own territory.Tensions were stoked again on Tuesday when Japanese lawmaker Hei Seki, who last year was sanctioned by China for “spreading fallacies” about Taiwan and other disputed territories, visited Taiwan and called it an independent country. Also known as Yo Kitano, he has been banned from entering China. He told reporters that his arrival in Taiwan demonstrated the two are “different countries.”“I came to Taiwan … to prove this point, and to tell the world that Taiwan is an independent country,” Hei Seki said, according to Taiwan’s Central News Agency.“The nasty words of a petty villain like him are not worth commenting on,” Chinese Foreign Ministry spokesperson Mao Ning retorted when asked about his comment. Fears of a rare earths curb Masaaki Kanai, head of Asia Oceanian Affairs at Japan's Foreign Ministry, urged China to scrap the trade curbs, saying a measure exclusively targeting Japan that deviates from international practice is unacceptable. Japan, however, has yet to announce any retaliatory measures.As the two countries feuded, speculation rose that China might target rare earths exports to Japan, in a move similar to the rounds of critical minerals export restrictions it has imposed as part of its trade war with the United States.China controls most of the global production of heavy rare earths, used for making powerful, heat-resistance magnets used in industries such as defense and electric vehicles.While the Commerce Ministry did not mention any new rare earths curbs, the official newspaper China Daily, seen as a government mouthpiece, quoted anonymous sources saying Beijing was considering tightening exports of certain rare earths to Japan. That report could not be independently confirmed. Improved South Korean ties contrast with Japan row As Beijing spars with Tokyo, it has made a point of courting a different East Asian power — South Korea.On Wednesday, South Korean President Lee Jae Myung wrapped up a four-day trip to China – his first since taking office in June. Lee and Chinese President Xi Jinping oversaw the signing of cooperation agreements in areas such as technology, trade, transportation and environmental protection.As if to illustrate a contrast with the China-Japan trade frictions, Lee joined two business events at which major South Korean and Chinese companies pledged to collaborate.The two sides signed 24 export contracts worth a combined $44 million, according to South Korea’s Ministry of Trade, Industry and Resources. During Lee’s visit, Chinese media also reported that South Korea overtook Japan as the leading destination for outbound flights from China’s mainland over the New Year’s holiday.China has been discouraging travel to Japan, saying Japanese leaders’ comments on Taiwan have created “significant risks to the personal safety and lives of Chinese citizens in Japan.”Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.Photos You Should See – December 2025

Pesticide industry ‘immunity shield’ stripped from US appropriations bill

Democrats and the Make America Healthy Again movement pushed back on the rider in a funding bill led by BayerIn a setback for the pesticide industry, Democrats have succeeded in removing a rider from a congressional appropriations bill that would have helped protect pesticide makers from being sued and could have hindered state efforts to warn about pesticide risks.Chellie Pingree, a Democratic representative from Maine and ranking member of the House appropriations interior, environment, and related agencies subcommittee, said Monday that the controversial measure pushed by the agrochemical giant Bayer and industry allies has been stripped from the 2026 funding bill. Continue reading...

In a setback for the pesticide industry, Democrats have succeeded in removing a rider from a congressional appropriations bill that would have helped protect pesticide makers from being sued and could have hindered state efforts to warn about pesticide risks.Chellie Pingree, a Democratic representative from Maine and ranking member of the House appropriations interior, environment, and related agencies subcommittee, said Monday that the controversial measure pushed by the agrochemical giant Bayer and industry allies has been stripped from the 2026 funding bill.The move is final, as Senate Republican leaders have agreed not to revisit the issue, Pingree said.“I just drew a line in the sand and said this cannot stay in the bill,” Pingree told the Guardian. “There has been intensive lobbying by Bayer. This has been quite a hard fight.”The now-deleted language was part of a larger legislative effort that critics say is aimed at limiting litigation against pesticide industry leader Bayer, which sells the widely used Roundup herbicides.An industry alliance set up by Bayer has been pushing for both state and federal laws that would make it harder for consumers to sue over pesticide risks to human health and has successfully lobbied for the passing of such laws in Georgia and North Dakota so far.The specific proposed language added to the appropriations bill blocked federal funds from being used to “issue or adopt any guidance or any policy, take any regulatory action, or approve any labeling or change to such labeling” inconsistent with the conclusion of an Environmental Protection Agency (EPA) human health assessment.Critics said the language would have impeded states and local governments from warning about risks of pesticides even in the face of new scientific findings about health harms if such warnings were not consistent with outdated EPA assessments. The EPA itself would not be able to update warnings without finalizing a new assessment, the critics said.And because of the limits on warnings, critics of the rider said, consumers would have found it difficult, if not impossible, to sue pesticide makers for failing to warn them of health risks if the EPA assessments do not support such warnings.“This provision would have handed pesticide manufacturers exactly what they’ve been lobbying for: federal preemption that stops state and local governments from restricting the use of harmful, cancer-causing chemicals, adding health warnings, or holding companies accountable in court when people are harmed,” Pingree said in a statement. “It would have meant that only the federal government gets a say – even though we know federal reviews can take years, and are often subject to intense industry pressure.”Pingree tried but failed to overturn the language in a July appropriations committee hearing.Bayer, the key backer of the legislative efforts, has been struggling for years to put an end to thousands of lawsuits filed by people who allege they developed cancer from their use of Roundup and other glyphosate-based weed killers sold by Bayer. The company inherited the litigation when it bought Monsanto in 2018 and has paid out billions of dollars in settlements and jury verdicts but still faces several thousand ongoing lawsuits. Bayer maintains its glyphosate-based herbicides do not cause cancer and are safe when used as directed.When asked for comment on Monday, Bayer said that no company should have “blanket immunity” and it disputed that the appropriations bill language would have prevented anyone from suing pesticide manufacturers. The company said it supports state and federal legislation “because the future of American farming depends on reliable science-based regulation of important crop protection products – determined safe for use by the EPA”.The company additionally states on its website that without “legislative certainty”, lawsuits over its glyphosate-based Roundup and other weed killers can impact its research and product development and other “important investments”.Pingree said her efforts were aided by members of the Make America Healthy Again (Maha) movement who have spent the last few months meeting with congressional members and their staffers on this issue. She said her team reached out to Maha leadership in the last few days to pressure Republican lawmakers.“This is the first time that we’ve had a fairly significant advocacy group working on the Republican side,” she said.Last week, Zen Honeycutt, a Maha leader and founder of the group Moms Across America, posted a “call to action”, urging members to demand elected officials “Stop the Pesticide Immunity Shield”.“A lot of people helped make this happen,” Honeycutt said. “Many health advocates have been fervently expressing their requests to keep chemical companies accountable for safety … We are delighted that our elected officials listened to so many Americans who spoke up and are restoring trust in the American political system.”Pingree said the issue is not dead. Bayer has “made this a high priority”, and she expects to see continued efforts to get industry friendly language inserted into legislation, including into the new Farm Bill.“I don’t think this is over,” she said.This story is co-published with the New Lede, a journalism project of the Environmental Working Group

Forever Chemicals' Common in Cosmetics, but FDA Says Safety Data Are Scant

By Deanna Neff HealthDay ReporterSATURDAY, Jan. 3, 2026 (HealthDay News) — Federal regulators have released a mandated report regarding the...

By Deanna Neff HealthDay ReporterSATURDAY, Jan. 3, 2026 (HealthDay News) — Federal regulators have released a mandated report regarding the presence of "forever chemicals" in makeup and skincare products. Forever chemicals — known as perfluoroalkyl and polyfluoroalkyl substances or PFAS — are manmade chemicals that don't break down and have built up in people’s bodies and the environment. They are sometimes added to beauty products intentionally, and sometimes they are contaminants. While the findings confirm that PFAS are widely used in the beauty industry, the U.S. Food and Drug Administration (FDA) admitted it lacks enough scientific evidence to determine if they are truly safe for consumers.The new report reveals that 51 forever chemicals — are used in 1,744 cosmetic formulations. These synthetic chemicals are favored by manufacturers because they make products waterproof, increase their durability and improve texture.FDA scientists focused their review on the 25 most frequently used PFAS, which account for roughly 96% of these chemicals found in beauty products. The results were largely unclear. While five were deemed to have low safety concerns, one was flagged for potential health risks, and safety of the rest could not be confirmed.FDA Commissioner Dr. Marty Makary expressed concern over the difficulty in accessing private research. “Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety,” Makary said in a news release, adding that “this lack of reliable data demands further research.”Despite growing concerns about their potential toxicity, no federal laws specifically ban their use in cosmetics.The FDA report focuses on chemicals that are added to products on purpose, rather than those that might show up as accidental contaminants. Moving forward, FDA plans to work closely with the U.S. Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) to update and strengthen recommendations on PFAS across the retail and food supply chain, Makary said. The agency has vowed to devote more resources to monitoring these chemicals and will take enforcement action if specific products are proven to be dangerous.The U.S. Food and Drug Administration provides updates and consumer guidance on the use of PFAS in cosmetics.SOURCE: U.S. Food and Drug Administration, news release, Dec. 29, 2025Copyright © 2026 HealthDay. All rights reserved.

Lawsuit claims worker suffered ‘chemical exposure’ from sulfuric acid leak in Houston Ship Channel

According to the lawsuit filed Wednesday, Jeffery Lee Lawson claims he suffered from “burning lungs, shortness of breath, pain in his throat, nausea, dizziness and skin irritation” as a result of the chemical leak. 

Court According to the lawsuit filed Wednesday, Jeffery Lee Lawson claims he suffered from “burning lungs, shortness of breath, pain in his throat, nausea, dizziness and skin irritation” as a result of the chemical leak.  Kyle McClenagan | Posted on January 2, 2026, 10:13 AM (Last Updated: January 2, 2026, 11:01 AM) Gail Delaughter/Houston Public MediaPictured is an aerial view of activity on the Houston Ship Channel in May 2019.A worker who was on a tanker ship in the Houston Ship Channel during a sulfuric acid leak last week has filed a lawsuit accusing the owner of the facility where the leak occurred of being "grossly negligent." According to the lawsuit filed Wednesday, Jeffery Lee Lawson claims he suffered from "burning lungs, shortness of breath, pain in his throat, nausea, dizziness and skin irritation" as a result of the chemical leak. The leak occurred in the early morning of Saturday, Dec. 27, after an elevated walkway collapsed and ruptured a pipeline at the BWC Terminals facility in Channelview, east of Houston. According to Harris County Judge Lina Hidalgo, approximately 1 million gallons of sulfuric acid were released as a result. Sign up for the Hello, Houston! daily newsletter to get local reports like this delivered directly to your inbox. At the time of the leak, Lawson was working as a tankerman on a ship about 500 feet from the BWC Terminals facility, according to the lawsuit. "At approximately 2 a.m., Mr. Lawson heard a loud crash and subsequently saw a large gas cloud being released from the terminal," the lawsuit claims. "No alarms, warnings, or notifications were provided by Defendants. Shortly thereafter, Mr. Lawson was enveloped by the toxic substance and began to suffer from immediate physical injuries." ProvidedA photo of the apparent sulfuric acid leak at the BWC Terminals facility near the Houston Ship Channel included in a lawsuit against the company.The lawsuit names BWC Terminals LLC and BWC Texas Terminals LLC as the defendants and accuses the company of over a dozen alleged "grossly negligent" acts, including several alleged safety failures and Occupational Safety and Health Administration (OSAH) violations. Sulfuric acid is a colorless, oily liquid that is highly corrosive. Exposure to it can cause skin burns and irritate the eyes, lungs and digestive system, according to the Centers for Disease Control and Prevention. It can also be fatal. In a statement to Houston Public Media on Friday, a BWC Terminals spokesperson declined to comment and said the company does not comment on pending litigation. "We remain committed to operating safely, responsibly, and in compliance with all applicable regulations," the spokesperson wrote in an email. The lawsuit is seeking damages for the alleged physical and mental harm caused by the leak, past and future medical expenses and lost wages. Lawson, a Harris County resident, is seeking over $1 million in damages, according to the lawsuit. Shortly after the leak, County Judge Hidalgo said during a news conference that two people were hospitalized and released, while 44 others were treated at the scene. Lawson was diagnosed with chemical exposure and inflammation of the lungs, according to the lawsuit. On Monday, BWC Terminals said in a statement that the majority of the sulfuric acid released went into a designated containment area, with an “unknown” amount entering the ship channel. The full extent of the possible environmental impact caused by the leak is currently unknown. No other lawsuits against BWC Terminals had been filed in Harris County as of Friday morning.

Suggested Viewing

Join us to forge
a sustainable future

Our team is always growing.
Become a partner, volunteer, sponsor, or intern today.
Let us know how you would like to get involved!

CONTACT US

sign up for our mailing list to stay informed on the latest films and environmental headlines.

Subscribers receive a free day pass for streaming Cinema Verde.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.